#ESC25: Ionis' study success in moderately high triglyceride levels raises the curtain for pivotal readout in severe disease

MADRID — Ionis Pharmaceuticals’ Tryngolza reduced triglycerides in patients with moderately high levels of these fat molecules in a late-stage test, according to data presented Saturday at the annual meeting of the European Society of Cardiology ...